Kosmix
One sec... we're building your guide for
Phase 2 Study
Phase 2 study
Overview
Health Providers & Organizations
Main ›
Related in the Kosmos
?
Clinical trial
Phase III
Phase II trial
Phase I trial
Medical statistics
Open label
Interim analysis
Phase 2 clinical trial
Clinical research
Clinical trials
Placebo
Placebo controlled study
Drug candidate
Phase 2 clinical trial
Open label
Pharmaceutical industry
Biopharmaceutical
Phase 2 clinical trial
Drug candidate
Microtubule inhibitors
Docetaxel
Paclitaxel
Taxane
Colchicine
Nocodazole
Vinblastine
Types of cancer
NSCLC
Hormone-refractory prostate cancer
Multiple myeloma
Medical terms
Progression Free Survival
Monotherapy
Patients
Placebo
Monoclonal antibodies
TNX-355
Bevacizumab
Trastuzumab
Rituximab
Cetuximab
Platinum compounds
Carboplatin
Oxaliplatin
Cisplatin
Orphan drugs
(57)
Bortezomib
Nexavar
Orphan drug
4-Aminopyridine
Acetohydroxamic acid
Acetohydroxamic acid
Alglucosidase alfa
Ambrisentan
Anagrelide
Anti-CD22 immunotoxins
Azacitidine
Bevacizumab
Bosentan
Busulfan
Carboprost
Carglumic acid
Carmustine
Cilengitide
Cladribine
Clofazimine
Cysteamine
Dasatinib
Deferasirox
Eculizumab
Eflornithine
Elesclomol
Eltrombopag
Fomivirsen
Gemtuzumab ozogamicin
Gusperimus
Icatibant
Idursulfase
Iloprost
Isofagomine tartrate
Mecasermin rinfabate
Miglustat
Mitotane
Nilotinib
Nitisinone
Oncophage
Paromomycin sulfate
Pazopanib
Pemtumomab
Plerixafor
Rifaximin
Rituximab
Romiplostim
Sacrosidase
Sodium phenylbutyrate
Sodium stibogluconate
Stiripentol
Terguride
Tetrabenazine
Tiopronin
Tiratricol
Trabectedin
Vorinostat
Xyrem
more...
Prodrugs
Irinotecan
Capecitabine
Temozolomide
Cyclophosphamide
Tyrosine kinase inhibitors
(15)
Erlotinib
Imatinib mesylate
Axitinib
Bosutinib
Cediranib
Cediranib
Dasatinib
Gefitinib
Lapatinib
Lestaurtinib
Nilotinib
Semaxanib
Sunitinib
Toceranib
Vandetanib
Vatalanib
more...
Chemotherapeutic agents
Sapacitabine
Lenalidomide
Anti-tumor
Taxane
Temozolomide
Pharmacology
(13)
Pharmaceuticals
Boceprevir
Ptc124
FOLFOX
Deforolimus
Deforolimus
Pharmacokinetics
Phase 2 clinical trial
Open label
Placebo
Monotherapy
Placebo controlled study
Drug candidate
Biopharmaceutical
more...
Diseases and disorders
(8)
Non-small cell lung cancer
Doxorubicin
Chronic hepatitis
NSCLC
Hormone-refractory prostate cancer
Hormone-refractory prostate cancer
Acute myeloid leukemia
Multiple myeloma
Chronic myeloid leukemia
more...
Oncology
Metastatic
J. Clin. Oncol.
Neoadjuvant
Ecog
Antineoplastic drugs
(130)
5-FU
Gemcitabine
Aclarubicin
Actinomycin
Alemtuzumab
Alemtuzumab
Alitretinoin
Altretamine
Aminolevulinic acid
Amsacrine
Anagrelide
Antiestrogen
Arsenic trioxide
Asparaginase
Azacitidine
Bevacizumab
Bexarotene
Bleomycin
Bortezomib
Bropirimine
Busulfan
Capecitabine
Carboplatin
Carboquone
Carmofur
Carmustine
Catumaxomab
Celecoxib
Cetuximab
Chlorambucil
Cisplatin
Cladribine
Clofarabine
Cyclophosphamide
Cytarabine
Dacarbazine
Dasatinib
Daunorubicin
Decitabine
Demecolcine
Denileukin diftitox
Docetaxel
Doxorubicin
Edrecolomab
Efaproxiral
Epirubicin
Erlotinib
Estramustine
Etoglucid
Etoposide
Everolimus
Fludarabine
Fotemustine
Fulvestrant
Gefitinib
Gemtuzumab ozogamicin
Hydroxyurea
Idarubicin
Ifosfamide
Imatinib mesylate
Irinotecan
Ixabepilone
Lapatinib
Lomustine
Lonidamine
Mannosulfan
Masoprocol
Mechlorethamine
Melphalan
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Miltefosine
Mitobronitol
Mitoguazone
Mitomycin
Mitotane
Mitoxantrone
Monomethyl auristatin E
Nafoxidine
Nelarabine
Nexavar
Nilotinib
Nimustine
Oblimersen
Oxaliplatin
Paclitaxel
Panitumumab
Pazopanib
Pegaspargase
Pemetrexed
Pentostatin
Personalized medicine
Picoplatin
Pipobroman
Pirarubicin
Plicamycin
Porfimer sodium
Prednimustine
Procarbazine
Raltitrexed
Reditux
Rituximab
Satraplatin
Semustine
Sparsomycin
Streptozotocin
Sunitinib
Tegafur
Temoporfin
Temozolomide
Temsirolimus
Teniposide
ThioTEPA
Tiazofurin
Tioguanine
Toceranib
Topotecan
Trabectedin
Trastuzumab
Treosulfan
Tretinoin
Triaziquone
Trofosfamide
Valrubicin
Vinblastine
Vincristine
Vindesine
Vinorelbine
Vorinostat
Zorubicin
more...
See also
(20)
PHASE 2
Phase One
Randomized
In phase
Albuferon
Albuferon
Vicriviroc
Double blind
Telaprevir
Preclinical
Initiates
Naproxcinod
Therapeutics
Peramivir
Sunitinib
Hepatitis C virus
Ribavirin
RTOG
HRPC
Dasatinib
Immunogenicity
more...
more categories...
Health Providers & Organizations
›
Vitals.com
